Lantern Pharma (LTRN) Short-term Investments (2021 - 2026)
Lantern Pharma's Short-term Investments was $701,085 in Q2 2026, down 92.9% from $9.84 million a year earlier and down 50.1% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Lantern Pharma came in at $5.7 million, down 65.5% from FY2024.
- Short-term Investments shows a four-year compound annual growth rate of -26.2% (FY2021 to FY2025).
- In earlier years, Short-term Investments was $16.5 million in FY2024 (-14.8%), $19.36 million in FY2023 (+7.6%), $17.99 million in FY2022 (-6.3%) and $19.2 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Short-term Investments in data going back to Q2 2021.
- Compared with a year earlier, Short-term Investments has declined for seven straight quarters, with an average decline of 53.0% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q4 2023 (growth of 7.6%); the worst was Q2 2026 (a decline of 92.9%).
- Per Business Quant data, LTRN's Short-term Investments in the three quarters before Q2 2026 was $1.41 million (Q1 2026), $5.7 million (Q4 2025) and $3.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn |
| 10 | Lantern Pharma | 7.95 Mn | -28.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 701,085.00 |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 5.70 Mn |
| Sep 30, 2025 | 3.97 Mn |
| Jun 30, 2025 | 9.84 Mn |
| Mar 31, 2025 | 13.34 Mn |
| Dec 31, 2024 | 16.50 Mn |
| Sep 30, 2024 | 19.95 Mn |
| Jun 30, 2024 | 20.29 Mn |
| Mar 31, 2024 | 20.00 Mn |
| Dec 31, 2023 | 19.36 Mn |
| Sep 30, 2023 | 19.35 Mn |
| Jun 30, 2023 | 19.53 Mn |
| Mar 31, 2023 | 19.06 Mn |
| Dec 31, 2022 | 17.99 Mn |
| Sep 30, 2022 | 18.57 Mn |
| Jun 30, 2022 | 18.79 Mn |
| Mar 31, 2022 | 18.56 Mn |
| Dec 31, 2021 | 19.20 Mn |
| Sep 30, 2021 | 19.16 Mn |
API Access
Lantern Pharma Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();